Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H32O2 |
Molecular Weight | 256.4241 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(O)=O
InChI
InChIKey=IPCSVZSSVZVIGE-UHFFFAOYSA-N
InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26393565Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12496284 | https://www.ncbi.nlm.nih.gov/pubmed/14717706 | https://www.ncbi.nlm.nih.gov/pubmed/18511927 | https://www.ncbi.nlm.nih.gov/pubmed/23406428
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26393565
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12496284 | https://www.ncbi.nlm.nih.gov/pubmed/14717706 | https://www.ncbi.nlm.nih.gov/pubmed/18511927 | https://www.ncbi.nlm.nih.gov/pubmed/23406428
Palmitic acid is a saturated fatty acid, the principal constituent of refined palm oil, present in the diet and synthesized endogenously. Palmitic acid is able to activate the orphan G protein-coupled receptor GPR40. Palmitic acid was also a weak ligand of peroxisome proliferator-activated receptor gamma. Palmitic acid is a ligand of lipid chaperones - the fatty acid-binding proteins (FABPs). Dietary palm oil and palmitic acid may play a role in the development of obesity, type 2 diabetes mellitus, cardiovascular diseases and cancer.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4422 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12496284 |
5.3 null [pEC50] | ||
Target ID: CHEMBL235 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14717706 |
156.0 µM [Kd] | ||
Target ID: CHEMBL3344 |
|||
Target ID: CHEMBL2083 |
|||
Target ID: CHEMBL3674 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | SURFAXIN Approved UseSURFAXIN is indicated for the prevention of respiratory distress syndrome
(RDS) in premature infants at high risk for RDS. Launch Date2012 |
PubMed
Title | Date | PubMed |
---|---|---|
Fatty acid and triglyceride composition of milk fat from lactating Holstein cows in response to supplemental canola oil. | 2001 Apr |
|
Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice. | 2001 Apr |
|
Identification of fatty acid molecules in a Fasciola hepatica immunoprophylactic fatty acid-binding protein. | 2001 Apr |
|
Effects of authentic and VLDL hydrolysis-derived fatty acids on vascular smooth muscle cell growth. | 2001 Apr |
|
Carotenoid esters in vegetables and fruits: a screening with emphasis on beta-cryptoxanthin esters. | 2001 Apr |
|
Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? | 2001 Apr |
|
Pulmonary surfactant protein SP-B is significantly more immunoreactive in anionic than in zwitterionic bilayers. | 2001 Apr 13 |
|
Thioacylation is required for targeting G-protein subunit G(o1alpha) to detergent-insoluble caveolin-containing membrane domains. | 2001 Apr 15 |
|
Regulation of surfactant-like particle secretion by Caco-2 cells. | 2001 Apr 2 |
|
Tolerance induction by acylated peptides: suppression of EAE in the mouse with palmitoylated PLP peptides. | 2001 Apr 2 |
|
Kinetics of the lipase-catalyzed synthesis of glucose esters in acetone. | 2001 Apr 20 |
|
Plasma membrane localization of palmitoylated tubulin. | 2001 Apr 27 |
|
Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. | 2001 Apr 27 |
|
Participation of carnitine palmitoyltransferase in the synthesis of dipalmitoylphosphatidylcholine in rat alveolar type II cells. | 2001 Feb |
|
A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males. | 2001 Feb |
|
Fatty acid-induced apoptosis in neonatal cardiomyocytes: redox signaling. | 2001 Feb |
|
Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. | 2001 Feb |
|
Myocardial fatty acid oxidation in patients with impaired glucose tolerance. | 2001 Feb |
|
Effect of fatty acids on phase behavior of hydrated dipalmitoylphosphatidylcholine bilayer: saturated versus unsaturated fatty acids. | 2001 Feb |
|
L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions. | 2001 Jan |
|
Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes. | 2001 Jun |
|
Systemic and regional free fatty acid metabolism in type 2 diabetes. | 2001 Jun |
|
Demonstration of direct effects of growth hormone on neonatal cardiomyocytes. | 2001 Jun 22 |
|
Gbeta gamma isoforms selectively rescue plasma membrane localization and palmitoylation of mutant Galphas and Galphaq. | 2001 Jun 29 |
|
Anaerobic biodegradation of alkanes by enriched consortia under four different reducing conditions. | 2001 Mar |
|
Optimization of methods and treatment conditions for studying effects of fatty acids on cell growth. | 2001 Mar |
|
Effects of diets enriched in n-6 or n-3 fatty acids on cholesterol metabolism in older rats chronically fed a cholesterol-enriched diet. | 2001 Mar |
|
Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. | 2001 Mar |
|
Gas chromatographic analysis of total fatty acids in cider. | 2001 Mar |
|
Modelling of hexadecane degradation in continuous-flow cultures. | 2001 Mar |
|
Effects of antiinflammatory triterpenes isolated from Leptadenia hastata latex on keratinocyte proliferation. | 2001 Mar |
|
Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics. | 2001 Mar 15 |
|
Regulation of G proteins by covalent modification. | 2001 Mar 26 |
|
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. | 2001 Mar 30 |
|
[Branched alkanes and other apolar compounds produced by the cyanobacterium Microcoleus vaginatus from the Negev desert]. | 2001 Mar-Apr |
|
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. | 2001 May |
|
Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. | 2001 May |
|
Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact. | 2001 May |
|
Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability. | 2001 May |
|
Effects of free fatty acids on beta-cell functions: a possible involvement of peroxisome proliferator-activated receptors alpha or pancreatic/duodenal homeobox. | 2001 May |
|
Imaging of monolayers composed of palmitic acid and lung surfactant protein B. | 2001 May |
|
The sites for fatty acylation, phosphorylation and intermolecular disulphide bond formation of influenza C virus CM2 protein. | 2001 May |
|
A high-sucrose diet increases gluconeogenic capacity in isolated periportal and perivenous rat hepatocytes. | 2001 May |
|
n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. | 2001 May |
|
Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible. | 2001 May 11 |
|
Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. | 2001 May 15 |
|
Differential palmitoylation of two mouse glutamate receptor interacting protein 1 forms with different N-terminal sequences. | 2001 May 18 |
|
Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase. | 2001 May 18 |
|
Physiological levels of mammalian uncoupling protein 2 do not uncouple yeast mitochondria. | 2001 May 25 |
|
Palmitate-induced apoptosis can occur through a ceramide-independent pathway. | 2001 May 4 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18710535
The conditioned media from palmitic acid (0.2 mM) treated rat cortical astroglia, but not the cerebellar astroglia, significantly elevated levels of phosphorylated tau and BACE1 in cortical neurons as compared to controls
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
47641-6
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
NCI_THESAURUS |
C68421
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
55873-4
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
2719-3
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/04/217
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
74625-5
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
DSLD |
1603 (Number of products:186)
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
75115-6
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
NCI_THESAURUS |
C68388
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
35161-9
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
JECFA EVALUATION |
PALMITIC ACID
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
CFR |
21 CFR 172.860
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
CFR |
21 CFR 357.210
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
74624-8
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5030
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
LL-31
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
15756
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1492007
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
PALMITIC ACID
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
57-10-3
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
100000091751
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
m8367
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | Merck Index | ||
|
5001
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
CHEMBL82293
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
C61873
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1091
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1426390
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB14744MIG
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
985
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
2V16EO95H1
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
200-312-9
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
7896
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
2V16EO95H1
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
DB03796
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
DTXSID2021602
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1370621
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
ALTERNATIVE | |||
|
D019308
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)